NCT06872567NARecruiting

Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain

North American Science Associates Ltd.

Start Date

10/1/2025

Completion Date

12/1/2026

Summary

Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection

Eligibility Criteria

Age Range: 40 years to No maximum

Inclusion Criteria: * Patient has localized knee pain * Must be an appropriate candidate for arterial vascular access procedure Exclusion Criteria: * Known sensitivity or allergy to implant materials * Unable or unwilling to comply with study requirements

Interventions

DEVICE

genicular artery embolization

DRUG

Corticosteroid Injection

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Knee Osteoarthritis (Knee OA)

Locations

University of Virginia

Charlottesville, Virginia 22903

United States